The APIS team will be exhibiting at AACC Annual Scientific Meeting & Clinical Lab Expo 2023. 

Be sure not to miss our team of experts at Booth 2482.

APIS is leveraging systems biology, interrogating multi-OMICs biodata, and deploying ‘Clickmer’ ligand binding technology, for the validation and translation of biomarker and therapeutics into clinical utility.

Find out about our expertise and capabilities in IVD development of molecular & immune-assays for product realisation as diagnostic tests. APIS expertise in bioinformatics is offered as an agile service, to develop bespoke, end-to-end multi-OMICs solutions and platform development.

The APIS Breast Cancer Subtyping Kit (RUO) is a highly reproducible, RT-qPCR based product for detecting standard (HER2, ER, PR, Ki67) and novel proliferative biomarkers.

The new APIS ESR1 Mutations Kit is a research use only, advanced qPCR assay for the sensitive and precise detection of mutations within the oestrogen receptor gene. The Kit is a qualitative test, detecting eleven ESR1 mutations across exons 5 (E380Q), 7 (S463P) and 8 (P535H, L536R, L536Q, L536H, L536P, Y537C, Y537S, Y537N and D538G).

Use this link to contact us and schedule a meeting.